MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin
Background/Aims: The microRNA (miR) 29 family has been studied extensively for its involvement in several diseases, and aberrant expression of its members is associated with tumorigenesis and cancer progression. Here, we examined the role of miR-29a in pancreatic cancer and the involvement of triste...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2015-09-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/430389 |
_version_ | 1818132214376824832 |
---|---|
author | Xian-Jun Sun Bing-Yan Liu Shuo Yan Ting-Hui Jiang Hui-Qin Cheng Hao-Sheng Jiang Yan Cao Ai-Wu Mao |
author_facet | Xian-Jun Sun Bing-Yan Liu Shuo Yan Ting-Hui Jiang Hui-Qin Cheng Hao-Sheng Jiang Yan Cao Ai-Wu Mao |
author_sort | Xian-Jun Sun |
collection | DOAJ |
description | Background/Aims: The microRNA (miR) 29 family has been studied extensively for its involvement in several diseases, and aberrant expression of its members is associated with tumorigenesis and cancer progression. Here, we examined the role of miR-29a in pancreatic cancer and the involvement of tristetraprolin (TTP). Methods: We monitored miR-29a and TTP expression in pancreatic cancer by qRT-PCR and western blotting. The effect of miR-29a on pancreatic cancer was determined through MTT assay and migration assay. The results were validated in the tumorigenesis model. Results: We found that miR-29a was up regulated in pancreatic tumor tissues and cell lines and positively correlated with metastasis. Ectopic expression of miR-29a increased the expression of pro-inflammatory factors and epithelial-mesenchymal transition (EMT) markers, through down regulating TTP. TTP was down regulated in tumor tissues, and its ectopic expression decreased cell viability and migration in vitro, inhibited tumor growth and the EMT phenotype in vivo, and reversed the effect of miR-29a on tumor cell proliferation and invasion in vitro and in vivo. Conclusion: Our results suggest that miR-29a acts as an oncogene by down regulating TTP and provide the basis for further studies exploring the potential of miR-29a and TTP as biomarkers and targets for the treatment of pancreatic cancer. |
first_indexed | 2024-12-11T08:33:16Z |
format | Article |
id | doaj.art-0b302604dc0e4a3286aa11b47d70e2c9 |
institution | Directory Open Access Journal |
issn | 1015-8987 1421-9778 |
language | English |
last_indexed | 2024-12-11T08:33:16Z |
publishDate | 2015-09-01 |
publisher | Cell Physiol Biochem Press GmbH & Co KG |
record_format | Article |
series | Cellular Physiology and Biochemistry |
spelling | doaj.art-0b302604dc0e4a3286aa11b47d70e2c92022-12-22T01:14:24ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782015-09-0137270771810.1159/000430389430389MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting TristetraprolinXian-Jun SunBing-Yan LiuShuo YanTing-Hui JiangHui-Qin ChengHao-Sheng JiangYan CaoAi-Wu MaoBackground/Aims: The microRNA (miR) 29 family has been studied extensively for its involvement in several diseases, and aberrant expression of its members is associated with tumorigenesis and cancer progression. Here, we examined the role of miR-29a in pancreatic cancer and the involvement of tristetraprolin (TTP). Methods: We monitored miR-29a and TTP expression in pancreatic cancer by qRT-PCR and western blotting. The effect of miR-29a on pancreatic cancer was determined through MTT assay and migration assay. The results were validated in the tumorigenesis model. Results: We found that miR-29a was up regulated in pancreatic tumor tissues and cell lines and positively correlated with metastasis. Ectopic expression of miR-29a increased the expression of pro-inflammatory factors and epithelial-mesenchymal transition (EMT) markers, through down regulating TTP. TTP was down regulated in tumor tissues, and its ectopic expression decreased cell viability and migration in vitro, inhibited tumor growth and the EMT phenotype in vivo, and reversed the effect of miR-29a on tumor cell proliferation and invasion in vitro and in vivo. Conclusion: Our results suggest that miR-29a acts as an oncogene by down regulating TTP and provide the basis for further studies exploring the potential of miR-29a and TTP as biomarkers and targets for the treatment of pancreatic cancer.http://www.karger.com/Article/FullText/430389Pancreatic cancerMicroRNA-29aTristetraprolin |
spellingShingle | Xian-Jun Sun Bing-Yan Liu Shuo Yan Ting-Hui Jiang Hui-Qin Cheng Hao-Sheng Jiang Yan Cao Ai-Wu Mao MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin Cellular Physiology and Biochemistry Pancreatic cancer MicroRNA-29a Tristetraprolin |
title | MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin |
title_full | MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin |
title_fullStr | MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin |
title_full_unstemmed | MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin |
title_short | MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin |
title_sort | microrna 29a promotes pancreatic cancer growth by inhibiting tristetraprolin |
topic | Pancreatic cancer MicroRNA-29a Tristetraprolin |
url | http://www.karger.com/Article/FullText/430389 |
work_keys_str_mv | AT xianjunsun microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin AT bingyanliu microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin AT shuoyan microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin AT tinghuijiang microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin AT huiqincheng microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin AT haoshengjiang microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin AT yancao microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin AT aiwumao microrna29apromotespancreaticcancergrowthbyinhibitingtristetraprolin |